| S7584 |
LRRK2-IN-1
|
LRRK2-IN-1 is a potent and selective LRRK2 inhibitor with IC50 of 6 nM and 13 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.
|
-
Invest Ophthalmol Vis Sci, 2025, 66(2):13
-
J Med Chem, 2021, 10.1021/acs.jmedchem.1c01096
-
ACS Chem Neurosci, 2021, 10.1021/acschemneuro.1c00399
|
|
| E0998 |
PFE-360
|
PFE-360(PF-06685360) is a brain-penetrant and selective LRRK2 small-molecule kinase inhibitors.
|
-
Viruses, 2022, 14(9)2058
|
|
| S9694 |
MLi-2
|
MLi-2 is an orally active and highly selective inhibitor of LRRK2. This compound exhibits exceptional potency in a purified LRRK2 kinase assay in vitro with IC50 of 0.76 nM, a cellular assay monitoring dephosphorylation of LRRK2 pSer935 LRRK2 with IC50 of 1.4 nM, and a radioligand competition binding assay with IC50 of 3.4 nM.
|
-
Exp Neurobiol, 2024, 33(1):36-45
|
|
| S7367 |
GNE-0877 (DNL201)
|
GNE-0877 (DNL201) is a highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor with Ki of 0.7 nM.
|
-
Cancer Discov, 2020, CD-20-0160
|
|
| S7528 |
GNE-7915
|
GNE-7915 is a highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor, with IC50 and Ki of 9 nM and 1 nM, respectively.
|
-
Am J Physiol Renal Physiol, 2018, 315(5):F1465-F1477
|
|
| S7664 |
GSK2578215A
|
GSK2578215A is a potent and selective LRRK2 kinase inhibitor with IC50 of 8.9 nM and 10.9 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.
|
-
J Exp Med, 2017, 214(10):3051-3066
|
|
| S6534 |
CZC-54252
|
CZC-54252 is a potent and selective LRRK2 inhibitor with IC50s of 1.28 nM and 1.85 nM for human wild type LRRK2 and G2019S LRRK2, respectively.
|
|
|
| S7368 |
GNE-9605
|
GNE-9605 is a highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor with Ki and IC50 of 2 nM and 19 nM, respectively.
|
|
|
| S2002 |
CZC-25146
|
CZC-25146 is a potent and selective LRRK2 inhibitor with IC50 of 4.76 nM and 6.87 nM for human wild type LRRK2 and G2019S LRRK2, respectively.
|
|
|
| S8202 |
PF-06447475
|
PF-06447475 is a potent, selective, and brain penetrant LRRK2 kinase inhibitor with IC50 of 3 nM.
|
|
|